Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
15.9 EUR | +0.89% | +0.89% | -40.67% |
Apr. 09 | BASTIDE LE CONFORT MEDICAL : EPS upgrade (2023: 0.0%, 2024: +1.6%) | |
Apr. 09 | Bastide: new contract with the British NHS | CF |
Sales 2024 * | 530M 566M | Sales 2025 * | 564M 603M | Capitalization | 117M 125M |
---|---|---|---|---|---|
Net income 2024 * | 16M 17.08M | Net income 2025 * | 22M 23.49M | EV / Sales 2024 * | 0.86 x |
Net Debt 2024 * | 337M 360M | Net Debt 2025 * | 331M 354M | EV / Sales 2025 * | 0.79 x |
P/E ratio 2024 * |
6.9
x | P/E ratio 2025 * |
5.05
x | Employees | 3,635 |
Yield 2024 * |
2.98% | Yield 2025 * |
3.07% | Free-Float | 44.92% |
1 day | +0.89% | ||
1 week | +0.89% | ||
Current month | +12.77% | ||
1 month | +5.30% | ||
3 months | -30.11% | ||
6 months | -22.63% | ||
Current year | -40.67% |
Managers | Title | Age | Since |
---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
Corporate Officer/Principal | 50 | 15-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
Vanessa Giraud
BRD | Director/Board Member | 50 | - |
Olivier Mares
BRD | Director/Board Member | 47 | 19-07-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 15.9 | +0.89% | 677 |
24-04-22 | 15.76 | +3.41% | 83,018 |
24-04-19 | 15.24 | -1.55% | 6,016 |
24-04-18 | 15.48 | -1.53% | 14,164 |
24-04-17 | 15.72 | -0.25% | 5,587 |
Real-time Euronext Paris, April 23, 2024 at 04:21 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-40.67% | 124M | |
-4.02% | 2.98B | |
0.00% | 1.82B | |
+0.69% | 1.5B | |
+49.78% | 626M | |
-0.87% | 515M | |
-37.21% | 366M | |
-13.94% | 136M | |
+1.92% | 67.64M |
- Stock Market
- Equities
- BLC Stock